Abstract

Extracorporeal membrane oxygenation (ECMO) is considered a salvage therapy in cases of severe acute respiratory distress syndrome (ARDS) with profound hypoxemia. However, the need for high-volume fluid resuscitation and blood transfusions after ECMO initiation introduces a risk of fluid overload. Positive fluid balance is associated with mortality in critically ill patients, and conservative fluid management for ARDS patients has been shown to shorten both the duration of mechanical ventilation and time spent in intensive care, albeit without a significant effect on survival. Nonetheless, few studies have addressed the influence of fluid balance on clinical outcomes in severe ARDS patients undergoing ECMO. In the current retrospective study, we examined the impact of cumulative fluid balance (CFB) on hospital mortality in 152 cases of severe ARDS treated using ECMO. Overall hospital mortality was 53.3%, and we observed a stepwise positive correlation between CFB and the risk of death. Cox regression models revealed that CFB during the first 3 days of ECMO was independently associated with higher hospital mortality (adjusted hazard ratio 1.110 [95% CI 1.027–1.201]; p = 0.009). Our findings indicate the benefits of a conservative treatment approach to avoid fluid overload during the early phase of ECMO when dealing with severe ARDS patients.

Highlights

  • Extracorporeal membrane oxygenation (ECMO) is considered a rescue therapy for life-threatening hypoxemia in patients with severe acute respiratory distress syndrome (ARDS) [1,2,3,4]

  • After adjusting for significant confounding variables, Cox proportional hazard regression models revealed that cumulative fluid balance (CFB) during the first 3 days of ECMO was independently associated with an increased risk of death when CFB was considered as a continuous variable

  • The primary insight gained in this research was the fact that excessive CFB during the first 3 days of ECMO was independently associated with an increased risk of death in severe ARDS patients

Read more

Summary

Introduction

Extracorporeal membrane oxygenation (ECMO) is considered a rescue therapy for life-threatening hypoxemia in patients with severe acute respiratory distress syndrome (ARDS) [1,2,3,4]. One randomized study reported that the use of a conservative fluid strategy in patients with ARDS could improve lung function and shorten the duration of mechanical ventilation and time spent in intensive care, albeit without a significant influence on 60-day mortality [14]. Previous studies have reported that early positive fluid balance was independently associated with mortality in patients undergoing ECMO support [16,17]; none of those studies focused on the subgroup of patients with severe ARDS receiving ECMO. Our objective in the current study was to investigate the effect of cumulative fluid balance (CFB) during the early phase of ECMO on clinical outcomes and hospital mortality in patients with severe ARDS

Study Design and Patients
Definitions
Data Collection
ECMO Systems
Statistical Analysis
Comparison of Survivors and Nonsurvivors
Outcomes
Factors Associated with Hospital Mortality
Comparisons of VV-ECMO- and VA-ECMO-Supported ARDS Patients
Discussion
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call